MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hep.31588

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2020

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.

Alonso López Sonia, Manzano María Luisa, Gea Francisco, Gutiérrez María Luisa, Ahumada Adriana Maria, Devesa María José, Olveira Antonio, Polo Benjamin Arturo, Márquez Laura, Fernández Inmaculada, Cobo Juan Carlos Ruiz, Rayón Laura, Riado Daniel, Izquierdo Sonia, Usón Clara, Real Yolanda, Rincón Diego, Fernández-Rodríguez Conrado M, Bañares Rafael

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Patients with hepatitis C virus (HCV) and advanced fibrosis remain at risk of hepatocellular carcinoma (HCC) after sustained viral response (SVR) and need lifelong surveillance. Because HCC risk is not homogenous and may decrease with fibrosis regression, we aimed to identify patients with low HCC risk based on the prediction of noninvasive markers and its changes after SVR.

APPROACH AND

RESULTS

This is a multicenter cohort study, including patients with HCV and compensated advanced fibrosis that achieved SVR after direct antivirals. Clinical and transient elastography (TE) data were registered at baseline, 1 year, and 3 years after the end of treatment (EOT). All patients underwent liver ultrasound scan every 6 months. Patients with clinical evaluation 1 year after EOT were eligible. Univariate and multivariate Cox regression analysis were performed, and predictive models were constructed. HCC occurrence rates were evaluated by Kaplan-Meier. Nine hundred and ninety-three patients were eligible (56% male; 44% female; median age 62 years), 35 developed HCC (3.9%), and the median follow-up was 45 months (range 13-53). Baseline liver stiffness measurement (LSM) (HR 1.040; 95% CI 1.017-1.064), serum albumin (HR 0.400; 95% CI 0.174-0.923), 1-year DeltaLSM (HR 0.993; 95% CI 0.987-0.998), and 1-year FIB-4 score (HR 1.095; 95% CI 1.046-1.146) were independent factors associated with HCC. The TE-based HCC risk model predicted 0% of HCC occurrence at 3 years in patients with score 0 (baseline LSM ≤ 17.3 kPa, albumin >4.2 g/dL, and 1-year DeltaLSM > 25.5%) versus 5.2% in patients with score 1-3 (Harrell's C 0.779; log-rank 0.002). An alternative model with FIB-4 similarly predicted HCC risk.

CONCLUSIONS

A combination of baseline and dynamic changes in noninvasive markers may help to identify patients with a very low risk of HCC development after SVR.

Для цитирования: Alonso López Sonia, Manzano María Luisa, Gea Francisco, Gutiérrez María Luisa, Ahumada Adriana Maria, Devesa María José, Olveira Antonio, Polo Benjamin Arturo, Márquez Laura, Fernández Inmaculada, Cobo Juan Carlos Ruiz, Rayón Laura, Riado Daniel, Izquierdo Sonia, Usón Clara, Real Yolanda, Rincón Diego, Fernández-Rodríguez Conrado M, Bañares Rafael. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.. Hepatology (Baltimore, Md.). 2020. DOI: 10.1002/hep.31588.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.